AGN helps stop further progression of primary brain injury and is a glutamate inhibitor. Main thing AGN has to overcome is that inhibiting Glutamate beyond 30 mins of Brian injury does the opposite in humans for neuronal survival and neurons begin to die without glutamate. AGN half life is 12 hours let’s see what happens. NYR inhibits TRPC channels which are found throughout the brain inhibiting calcium influx in neurons
AGN Has nothing to do with secondary brain injury and cardiovascular protection. NYR has a larger target market. Different drug
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Dosing Update No 1
NYR
nyrada inc.
Add to My Watchlist
10.2%
!
22.0¢

Ann: Phase I Clinical Trial Dosing Update No 1, page-6
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.0¢ |
Change
-0.025(10.2%) |
Mkt cap ! $46.40M |
Open | High | Low | Value | Volume |
24.5¢ | 25.0¢ | 22.0¢ | $256.0K | 1.085M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67420 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 25083 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 67420 | 0.220 |
1 | 100000 | 0.215 |
2 | 50000 | 0.210 |
1 | 50000 | 0.205 |
4 | 121224 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 25083 | 2 |
0.235 | 106360 | 1 |
0.245 | 100000 | 1 |
0.255 | 25000 | 1 |
0.260 | 54498 | 2 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |